Table of Contents

company-logo

Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxisome proliferator-activated receptor alpha that is in a Phase 1 trial in solid tumors. It also develops TREX-1, a key cellular enzyme that regulates the innate immune response in tumors. The company was founded in 2011 and is headquartered in South San Francisco, California. Tempest Therapeutics Inc. was formerly a subsidiary of Inception Sciences, Inc.

Tempest Therapeutics Dividend Announcement

• Tempest Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Tempest Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Tempest Therapeutics Dividend History

Tempest Therapeutics Dividend Yield

Tempest Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Tempest Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Tempest Therapeutics Financial Ratios

P/E ratio-0.66
PEG ratio-0.14
P/B ratio2.06
ROE-187.44%
Payout ratio0.00%
Current ratio1.69
Quick ratio1.69
Cash Ratio1.58

Tempest Therapeutics Dividend FAQ

Does Tempest Therapeutics stock pay dividends?
Tempest Therapeutics does not currently pay dividends to its shareholders.
Has Tempest Therapeutics ever paid a dividend?
No, Tempest Therapeutics has no a history of paying dividends to its shareholders. Tempest Therapeutics is not known for its dividend payments.
Why doesn't Tempest Therapeutics pay dividends?
There are several potential reasons why Tempest Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Tempest Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Tempest Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Tempest Therapeutics a dividend aristocrat?
Tempest Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Tempest Therapeutics a dividend king?
Tempest Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Tempest Therapeutics a dividend stock?
No, Tempest Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Tempest Therapeutics stocks?
To buy Tempest Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Tempest Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.